EUVIMEDEUVIMED entdecken
Crossref

Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats

Ana Paula Ames-Sibin, Any Carolina Chagas-Almeida, Ana Beatriz P Souza, Ana Paula M Andrade iD, Juliana C Castro, Sabrina B S Ferreira, Francielli Maria S Silva-Comar, Roberto K N Cuman, Marcos L Bruschi iD, Maria Raquel M Natali, Anacharis B Sá-Nakaninhi, Lívia Bracht iD und 2 weitere

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Ana Paula Ames-Sibin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, State University of Maringá, 87020900, PR, Brazil. Hauptthemen laut MEDLINE: Arthritis, Experimental, Oils, Volatile, Fabaceae, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Copaiba essential oil (CEO) is obtained through the distillation of copaiba balsam and has been used in the traditional medicine to treat inflammatory conditions. However, the highly lipophilic nature of CEO restricts its pharmaceutical use. This study evaluated the effect of CEO, carried in a self-nanoemulsifying drug delivery system (SNEDDS), on articular and systemic inflammation and liver changes in Holtzman rats with Freund’s adjuvant-induced arthritis.

Methods

Healthy and arthritic rats received orally for 18 days the non-formulated CEO and the one carried in a self-nanoemulsifying drug delivery system (FSNEDDS), both at doses of 50 and 100 mg/kg. The oral bioavailability of FSNEDDS was determined in healthy rats by quantifying the levels of β-caryophyllene in the plasma. Key findings FSNEDDS exhibited more than three times greater oral bioavailability compared to non-formulated CEO. This phenomenon allowed FSNEDDS (100 mg/kg) to effectively reduce adjuvant-induced articular and systemic inflammation and oxidative stress in arthritic rats at a dose four times lower than copaiba balsam and β-caryophyllene. Furthermore, FSNEDDS did not alter the serum markers of liver damage, hepatic morphometry, and liver gluconeogenesis in healthy rats.

Conclusion

FSNEDDS was effective against arthritis in rats, and unlike copaiba balsam, it does not exhibit hepatotoxicity, suggesting it could serve as a phytotherapeutic alternative in the treatment of rheumatoid arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalOils, VolatileFabaceaeDrug Delivery SystemsPlant OilsAnti-Inflammatory AgentsAnimalsRatsEmulsionsMaleBiological AvailabilityFreund's AdjuvantOxidative StressAdministration, OralRats, Sprague-DawleyLiverPolycyclic SesquiterpenesInflammationSesquiterpenes

Stichwörter der Autor:innen

SNEDDSadjuvant-induced arthritiscopaiba essential oilgluconeogenesishepatotoxicityrheumatoid arthritis

Substanzen

Oils, VolatileEmulsionsFreund's AdjuvantPlant OilsAnti-Inflammatory AgentsPolycyclic SesquiterpenescaryophylleneSesquiterpenes

Autor:innen und Institutionen

  • Department of Biochemistry, State University of Maringá, 87020900, PR, Brazil.
  • Department of Basic Health Sciences, State University of Maringa, PR, Brazil.
  • Laboratory of Research and Development of Drug Delivery Systems (LABSLIF), State University of Maringá, 87020900, PR, Brazil.
  • Department of Pharmacology and Therapeutics, State University of Maringa, PR, Brazil.
  • Department of Morphological Sciences, State University of Maringa, PR, Brazil.

ORCID-Profile: Ana Paula M Andrade, Marcos L Bruschi, Lívia Bracht, Jurandir F Comar

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Ames-Sibin, A. P., Chagas-Almeida, A. C., Souza, A. B. P., Andrade, A. P. M., Castro, J. C., Ferreira, S. B. S., Silva-Comar, F. M. S., Cuman, R. K. N., Bruschi, M. L., Natali, M. R. M., Sá-Nakaninhi, A. B., Bracht, L., Bracht, A., & Comar, J. F. (2025). Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae154

Vancouver

Ames-Sibin AP, Chagas-Almeida AC, Souza ABP, Andrade APM, Castro JC, Ferreira SBS, et al. Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae154

BibTeX
@article{AmesSibin2025,
  author = {Ames-Sibin, Ana Paula and Chagas-Almeida, Any Carolina and Souza, Ana Beatriz P and Andrade, Ana Paula M and Castro, Juliana C and Ferreira, Sabrina B S and Silva-Comar, Francielli Maria S and Cuman, Roberto K N and Bruschi, Marcos L and Natali, Maria Raquel M and Sá-Nakaninhi, Anacharis B and Bracht, Lívia and Bracht, Adelar and Comar, Jurandir F},
  title = {Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae154}
}
Kostenlos starten →